NDC 16729-367-45 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-367
- Requested NDC
- 16729-367-45
- Package NDCs from labels
- 16729-367-10, 16729-367-15, 16729-367-16, 16729-367-17, 16729-367-45, 16729-367-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2024-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-367-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-367-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-367-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-367-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-367-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-367-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-367-10 | EA - Each | 16729-367 | aea7451f-249f-4002-a7df-f367e3bb0513 | 1 | 2020-09-14 |
| 16729-367-15 | EA - Each | 16729-367 | 0eff996a-5135-4a4b-a09e-70ccc66334d4 | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dr Lift Mineral SPF 30 | TITANIUM DIOXIDE | Spa de Soleil | 40c0e0d2-2c1d-e629-e063-6394a90a5aaf | 2025-10-09 | Warnings | 15FIX9V2JP |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 38f7f201-3a3a-4922-bde7-d34187b4c81d | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Essential Defense Mineral Shield Broad Spectrum SPF 35 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Allergan, Inc. | 29817fdc-f14c-4013-a8ed-4367f3b2867c | 2025-10-09 | Warnings | 15FIX9V2JP |
| Vertra Pearl White Face Stick SPF 50 | PADIMATE O, TITANIUM DIOXIDE | Eai-jr 286, Inc | b69a75e0-8724-35ae-e053-2a95a90a5f34 | 2025-10-07 | Warnings | 15FIX9V2JP |
| Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige | TITANIUM DIOXIDE | EAI-JR 286, Inc. | b9ea12e8-6ed9-d805-e053-2a95a90aa107 | 2025-10-07 | Warnings | 15FIX9V2JP |
| SPF50 Sunscreen | SUNSCREEN | KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD | b3cde609-7d62-2ac7-e053-2a95a90a26b3 | 2025-10-07 | 15FIX9V2JP | |
| Avalide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Sanofi-Aventis U.S. LLC | 0d91895e-c869-4b33-9b83-d55c1ad6317e | 2025-10-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige | TITANIUM DIOXIDE | Toshiki Pigment Co., Ltd. | b9eba15f-493a-43c9-e053-2995a90a0451 | 2025-10-06 | Warnings | 15FIX9V2JP |
| PURE SOL SPF 37 Tinted Moisturizer | ZINC OXIDE TITANIUM DIOXIDE | Brand 2022b LLC | 4052c4e4-2105-80c0-e063-6294a90af41d | 2025-10-04 | Warnings | 15FIX9V2JP |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | e43e5643-b258-469d-812a-887f913cfe71 | 2025-10-03 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | d09747f0-029e-4090-949b-e939948249b5 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 0a34f28c-20e6-4f34-9c4a-70fb258aa300 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Kids Mineral Sunscreen SPF50 | SUNSCREEN | Hello Bello | 01cc554b-9241-d891-e063-6394a90a8450 | 2025-10-02 | Warnings | 15FIX9V2JP |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 8a3e5be8-0a4b-48a0-817f-6e3c7674109d | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 89d367b1-de04-4970-9967-27a1c7711c0f | 2025-10-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 1dc47186-3ecf-456f-b6d6-ba0f75c2504b | 2025-10-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | BluePoint Laboratories | 4f44fb73-7f61-4623-ae89-61abd8e945ab | 2025-09-30 | Warnings, Adverse reactions | 0J48LPH2TH |
| toty Ilumina CC Creamy Compact Refill 1C | TITANIUM DIOXIDE | Chipican LLC | f0596830-77ed-11f0-e053-2995a90a8ff5 | 2025-09-29 | Warnings | 15FIX9V2JP |
| U V-Lamp Shield Mani-Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | GUANGZHOU SAWEILAN IMPORT & EXPORT TRADING CO., LTD | 3fe7e1c3-e6cd-1420-e063-6394a90a4138 | 2025-09-28 | Warnings | 15FIX9V2JP |
| olmesartan medoxomil-hydrochlorothiazide | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | Novadoz Pharmaceuticals LLC | c8197eea-e990-4c0e-bc2d-f080bac8de17 | 2025-09-26 | Boxed warning, Warnings, Adverse reactions | 403855 403853 403854 0J48LPH2TH 6M97XTV3HD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.